Gene Query: STK3

Dataset Description Geneva Score
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition [RNA-seq] 87.92
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition 87.92
Virus Mimicry in the Tumor Microenvironment Activates RIG-I Through Unshielding of Endogenous RNA in Exosomes [RNA-Seq] 46.34
41.05
Paxillin regulates genomic networks in prostate cancer [C4-2] 35.31
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 22.93
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression and cell death 20.65
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 20.29
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 19.16
Genome-wide functional assessment of enhancer activities in the human genome 16.68
Gene expression profiling of LNCaP cells following shRNA-mediated knockdown of TMEFF2 and growth in presence and absence of dihydrotestosterone 15.89
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 15.71
Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells 15.6
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 14.44
RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids 14.13
Aortic Valve Tissue: Stenosis vs. Sclerosis 13.87
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 13.65
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 13.43
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 12.76
Transcriptomic analyssis following EHMT1/2 inhibition 12.69
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 12.46
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 12.29
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 12.14
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 11.67
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 10.83
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 10.83
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 10.81
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 10.49
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 10.49
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 10.19
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 10.18
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 10.05
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 10.05
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 9.95
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 9.9
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 9.9
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 9.79
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 9.78
Paxillin regulates genomic networks in prostate cancer [LNCaP] 9.74
circRNA-sequencing 9.65
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 9.59
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 9.35
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 9.19
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 9.12
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 8.92
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 8.69
Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoids culture 8.65
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 8.64
Reassessment of Exosome Composition 8.61
DUX4 recruits p300/CBP through its C-terminus and induces global H3K27 acetylation changes 8.49
Mouse Dux is myotoxic and shares partial functional homology with its human paralog DUX4 8.25
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 8.22
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 8.04
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 7.98
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 7.94
MULTI-seq: Universal sample multiplexing for single-cell RNA sequencing using lipid-tagged indices 7.57
STRIPAK directs PP2A activity to promote oncogenic transformation 7.54
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 7.53
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 7.3
Primate transcript and protein expression levels evolve under compensatory selection pressures 7.13
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 7.1
The human blood-nerve barrier transcriptome 7.02
A transcriptome dataset revealing the molecular features of breast cancer stem cells 7.0
Cellular recruitment by podocyte-derived pro-migratory factors in assembly of the human renal filter 6.97
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 6.91
G-quadruplex structures mark human regulatory chromatin 6.8
Transcriptome of diurnal human blood neutrophils 6.67
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 6.66
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 6.52
LncRNA-GAS5 negative regulation of YAP-target genes expression 6.47
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 6.46
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 6.45
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 6.38
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 6.34
TGF-β regulation of miRNA expression in pancreatic cancer 6.32
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 6.28
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 6.27
Effect of CHKA knockdown on C4-2 cell transcriptome 6.2
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing 6.09
Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion 6.08
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 5.99
Role for citron kinase in prostate cancer growth 5.97
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 5.9
Human cell line and subcutaneous tumor 5.89
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 5.87
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 5.85
UBE3A-mediated regulation of imprinted genes and epigenome-wide marks in human neurons 5.74
Transcriptional profiling of microglia; current state of the art and future perspectives 5.69
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 5.68
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 5.62
Nuclear HNRNPA2B1 HITS-CLIP and RNA-seq 5.52
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 5.52
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 5.49
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 5.49
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 5.49
Analysis of transcriptional regulation by Myt1 and Myt1l 5.43
Global Mapping of Human RNA-RNA Interactions 5.4
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 5.4
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 5.33
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 5.33
Intrahepatic MAIT cell gene expression revealed by RNA-seq 5.27
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 5.23
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 5.23
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 5.18
HNRNPL and its RNA Targets in Prostate Cancer 5.18
6mer seed toxicity in tumour suppressive microRNAs 5.17
Transcriptome profiling in primary human skeletal myotubes with MondoA knockdown 5.16
MondoA Links Muscle Lipid Accumulation and Insulin Resistance Driven by Nutrient Overload 5.16
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 5.15
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 5.15
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells  5.08
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 5.07
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 5.06
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 5.06
CRISPR-Cas9 combinatorial KO of epigenetic regulators in human ovarian cancer cells 4.97
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 4.95
RNA sequencing of primary human platelets and in vitro cell lines 4.94
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 4.93
Effect of CTCF and Rad21 knockdown on SLK cells and KSHV gene expression 4.91
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 4.84
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 4.84
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 4.79
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 4.72
CASZ1 directly regulates expression of myogenic genes through regional epigenetic modifications to induce muscle and rhabdomyosarcoma cell differentiation 4.71
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 4.7
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 4.64
Targeted enhancer activation by a subunit of the integrator complex 4.63
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 4.62
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression (RNA-seq) 4.61
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression 4.61
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 4.54
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 4.5
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 4.5
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 4.5
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 4.49
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 4.48
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 4.47
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 4.46
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 4.4
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 4.35
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence [RNA-seq] 4.35
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence 4.35
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 4.34
Electronic cigarettes 4.31
The effect of engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 4.3
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 4.28
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 4.27
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 4.25
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 4.24
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 4.19
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 4.19
Microprocessor mediates transcription termination in long noncoding microRNA genes 4.18
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 4.18
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 4.17
MYCL and EP400 are required for Max and MCPyV mediated gene activation 4.17
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 4.16
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 4.16
Primary human trophoblast from term placenta 4.13
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 4.13
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 4.13
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 4.12
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division 4.11
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 4.11
Transcripotome analysis of different locations of hair follicles (bulb, bulge) in androgenetic alopecia 4.11
Transcriptional response to the HSP70 inhibitor MAL3-101 in parental rhabdomyosarcoma cells and isogenic acquired-resistance lines. 4.11
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 4.08
Recovery and analysis of nascent RNA 4.08
Expression by CD133+ cells isolated from the adult human exocrine pancreas 4.08
Selective expression of long non-coding RNAs in a breast cancer cell progression model 4.06
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 4.03
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 4.03
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 4.02
Human neutrophil genome during PMA- and E. coli encounter-induced activation 4.02
Effect of PBK knockdown on C4-2 cell transcriptome 4.02
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 4.01
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 4.01
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 4.01
Generating Patterned Kidney Organoids for Studying Development and Diseases 3.98
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 3.96
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 3.92
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 3.92
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 3.91
Triple vectors expand AAV transfer capacity in the retina 3.91
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 3.9
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 3.86
Transcriptome analysis of H9 hESC derived cerebral organoids 3.83
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] 3.83
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells 3.83
RNA-seq analysis of melanoma and carcinoma cells expressing FOXQ1 3.82
RNASeq of 4SU labelled nascent RNA in MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 3.81
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 3.81
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 3.81
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 3.77
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 3.77
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 3.75
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 3.75
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 3.74
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 3.74
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 3.74
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 3.72
RNA-seq of tumor cells following angiopellosis extravasation 3.71
T47D RNA-seq and ChrRNA-seq data 3.71
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 3.71
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 3.7
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 3.69
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 3.69
The mRNA expression analysis of psoriasis skin lesion mesenchymal stem cell 3.67
SLIGRL-induced gene expression changes in NHEK cells 3.67
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 3.66
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 3.64
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 3.64
High-throughput sequencing of PROMPT-enriched samples. 3.56
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 3.55
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 3.55
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 3.55
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 3.54
Transcriptome analysis of fetal Klinefelter testis tissue samples compared to controls 3.5
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 3.49
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 3.49
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 3.47
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 3.46
RNA m5C Methylation in breast cancer using MeRIP-Seq 3.44
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 3.44
Investigation about fibroblasts of different origins in culture 3.42
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 3.42
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 3.38
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 3.38
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 3.38
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 3.37
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 3.36
Tracking distinct RNA populations using efficient and reversible covalent chemistry 3.32
Single-cell analysis of human kidney organoids 3.31
Reconstitution of the human pancreatic niche stimulates differentiation of hESCs into beta cells and reveals new signals for pancreatic endocrine cell maturation 3.29
SRSF2 mutations impair hematopoiesis and alter exon recognition 3.29
Total RNA-seq in ALL-SIL upon TLX1 knockdown 3.28
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 3.27
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 3.25
Subcellular RNA fractions of HSV-1 infected primary human fibroblasts 3.23
RNA-seq of MCF10A cells and CAF 3.22
Characterization of sperm lncRNA and its differently expression in the sperm of asthenozoospermic patients 3.17
RNASeq of MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 3.17
Functional interdependency of BRD4 and DOT1L in MLL leukaemia 3.17
Low H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 3.12
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 3.11
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 3.11
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 3.1
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 3.09
STX4 Over-Expression in Human islets 3.08
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 3.05
RNA-seq of MDA-MB-231 cells with TET1 knockout 3.05
HEK293 Heat-shock experiment 3.03
An interaction with Ewing's sarcoma breakpoint protein EWS defines the specific oncogenic mechanism of ETS factors rearranged in prostate cancer 2.97
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 2.95
Generation of induced keratinocyte stem cells from human urine cells by defined transcription factors 2.87
Exploring the RNA landscape of endothelial exosomes 2.87
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 2.86
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 2.86
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 2.84
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 2.84
Downregulation of LATS kinases alters p53 to promote cell migration 2.8
In vitro modeling of human germ cell development using pluripotent stem cells 2.77
RNA-Seq with DHT induction and/or GSK treatment at 24, 48 hrs and 2 weeks 2.77
FOXA1 Chromatin Binding is Regulated by LSD1-Mediated Demethylation 2.77
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 2.76
RNA-sequencing of human mammary epithelial cells (HMLEs) transduced in vitro with a shRNA against SOX4 or a scrambled shRNA in untreated and TGF-β-treated (16 hours) conditions 2.75
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 2.74
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 2.73
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 2.73
Role of COP1 on MAP kinase transcriptional output in melanoma 2.72
Mutant p63 disrupts the key specification switch from the multipotent cell state to stratified epithelia during epithelial differentiation/in ectodermal dysplasia disorders 2.72
RNA sequencing analysis of selumetinib-resistant CRC cells lines 2.72
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 2.68
Effect of nuclear IL-33 on gene expression 2.66
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 2.63
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 2.63
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 2.61
RNA-sequencing 2.61
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 2.6
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 2.58
Integrative analysis of RNA, translation and protein levels reveals distinct regulatory variation across humans 2.58
The pause-initiation limit restricts transcription activation in human cells 2.51
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 2.49
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 2.45
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 2.45
Human iPSC-derived cells and microengineered Organ-Chip enhance neural development. 2.45
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 2.43
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 2.43
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 2.43
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 2.43
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 2.4
single cell RNA-seq from GM12878 (ENCSR673UIY) 2.39
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 2.36
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 2.34
Effect of SF3B1 suppression in cancer cells with different SF3B1 copy-number levels 2.29
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 2.27
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 2.26
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 2.26
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 2.22
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 2.22
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 2.21
MicroRNA-125a-5p overexpression in human macrophages 2.18
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 2.17
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 2.17
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 2.14
Xeno-free and Chemically Defined Human System for Culturing Human Epidermal Keratinocytes 2.12
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 2.11
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 2.11
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 2.1
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 2.1
Androgen Receptor-regulated genes in prostate cancer cells 2.08
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells 2.08
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 2.06
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 2.06
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 2.05
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 2.03
Depicting early human development and germ cell origin with porcine embryos 2.02
Expression profiling of MCF-7 cells with treatment of TCDD 1.99
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 1.99
Single-cell analysis of adult human ovary using 10X genomics 1.98
The Genetic Landscape of Diamond-Blackfan Anemia 1.98
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 1.98
Comparing effects of perfusion and hydrostatic pressure on human chondrocytes using gene profiles 1.96
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 1.93
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 1.93
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 1.92
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 1.89
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 1.89
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms 1.88
Transcriptome analysis of human airway epithelium infected by Human Bocavirus 1 1.87
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 1.86
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 1.86
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 1.86
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 1.8
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 1.79
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 1.77
Genome-wide maps of chromatin state and mRNA expression patterns in leukemic cell lines 1.75
JAG1 Mediated Notch Signaling Regulates Secretory Cell Differentiation of the Human Airway Epithelium 1.75
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 1.73
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 1.73
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 1.73
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 1.71
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 1.69
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 1.69
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 1.67
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 1.66
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 1.65
Identification of HOXB13 target genes responsive to BET inhibitors 1.63
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 1.59
Long non-coding RNA expression profile associated with malignant progression of oral submucous fibrosis 1.58
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 1.57
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 1.56
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 1.55
Deletions in the ATAD3 gene cluster cause cerebellar developmental defects with mitochondrial DNA abnormalities owing to local cholesterol insufficiency 1.54
Metastasis in triple-negative breast cancer 1.46
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 1.46
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 1.45
mRNA-Seq profiling SIX2+ and Foxd1+ cells in mouse embryonic and SIX2+ and SIX2-/MEIS1+ cells human fetal kidney 1.43
RNAseq of T-ALL upon long non coding rna purturbation 1.42
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 1.42
Transposon-based construction of strand-specific RNA-seq libraries 1.36
Codon usage optimization in pluripotent embryonic stem cells [tRNA sequencing] 1.32
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 1.3
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 1.29
RNAseq of Breast cancer PDX samples 1.26
Epigenetic reprogramming of melanoma cells by vitamin C treatment 1.24
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 1.24
Identification of Atrial Fibrillation associated genes and functional non-coding variants 1.23
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 1.23
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 1.23
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment 1.21
A single-cell transcriptome atlas of the human pancreas 1.19
The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma [RNA-Seq Tumor] 1.19
LINE-2 transposable elements are a source of functional human microRNAs and target sites 1.18
RNA sequencing of Formalin-Fixed, Paraffin-Embedded Specimens for Gene Expression Quantification and Data Mining 1.17
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner 1.17
Differences in miRNA Detection Levels are Technology and Sequence Dependent 1.15
Differences in miRNA Detection Levels are Technology and Sequence Dependent [NGS] 1.15
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 1.14
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF 1.1
IFN-γ Represses M2 Gene Expression in Human Macrophages by Suppressing and Disassembling MAF-binding Enhancers [RNA-seq] 1.1
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 1.1
Identification of miRNA signatures during the differentiation of hESCs into retinal pigment epithelial cells 1.09
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 1.08
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 1.07
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 1.07
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 1.06
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 1.06
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 1.06
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 1.06
RNA-sequencing transcriptome profiling of normal human keratinocytes differentiation 1.04
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 1.02
AQP5-Expressing Cells Serve as Stem Cells and Cancer Origins in the Distal Stomach 1.01
Integrin signaling regulates YAP/TAZ to control skin homeostasis 1.01
siRNA-mediated knockdown 0.95
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 0.94
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 0.94
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 0.92
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 0.9
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 0.9
mRNA-sequencing of breast cancer subtypes and normal tissue 0.89
Myc activation coordinates gene transcription and protein translation responses 0.89
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 0.89
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 0.89
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype 0.89
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype [RNA-seq] 0.89
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 0.87
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 0.83
Dilated cardiomyopathy vs Myocarditis 0.83
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 0.79
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 0.78
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 0.77
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 0.76
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 0.75
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 0.73
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 0.72
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.72
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.72
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 0.72
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 0.71
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas 0.7
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas [RNA-Seq] 0.7
Human Pancreatic Islets Expressing HNF1A Variant Have Defective β cell Transcriptional Regulatory Networks 0.69
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 0.69
Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapy 0.68
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 0.67
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 0.64
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 0.61
The transcriptomic landscape of MAIT cell development in the thymus (C006 RNAseq data set) 0.58
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 0.58
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 0.55
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 0.55
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 0.55
Gene expression analysis of human hepatocellular cancers 0.53
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 0.51
Folate modulation induces chromosomal instability and higher proliferation of immortalized human keratinocytes 0.5
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 0.48
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 0.48
RNA-seq data 0.45
Transcriptomic analysis of ERR alpha orphan nuclear receptor 0.45
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 0.43
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 0.42
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 0.42
BASP1 modifies the Tamoxifen response 0.41
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 0.4
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 0.39
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 0.38
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain [RNA-Seq] 0.36
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain 0.36
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.36
Transcriptome of EBV-infected gastric cancer cell lines 0.35
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 0.33
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 0.33
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 0.33
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 0.31
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 0.31
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 0.3
Profiling in vivo Bone Lesion (IVBL) and Orthotopic tumors by Next Generation Sequencing 0.3
Human Tfh cell RNA bulk sequencing 0.29
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 0.28
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 0.27
Polarized B -cell functions 0.27
Illumina HiSeq Sequencing on Breast cancer PDX samples 0.27
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 0.25
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 0.25
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 0.24
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 0.22
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.21
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.21
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 0.21
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 0.19
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 0.19
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 0.18
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 0.18
A rare subpopulation of melanoma cells with low expression of metastasis suppressor NME1 has a neural crest-like phenotype and is highly metastatic in vivo 0.17
MCF-7 as a model for functional analysis of breast cancer risk variants 0.16
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 0.16
IMP3 regulated gene expression in breast cancer cells 0.15
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 0.13
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 0.12
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 0.1
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes 0.1
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 0.1
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 0.1
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 0.09
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 0.09
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 0.09
Transcriptomic analysis of LSD1 0.08
SF3B1 Degron knockdown RNA-seq 0.06
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 0.04
Global transcriptome analysis of WT versus HEB-/- hESCs 0.04
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 0.03
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.03
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 0.03
Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia 0.02
Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD-linked Risk Locus 19q13.2 0.02
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium [RNA-Seq] 0.02
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium 0.02
Preclinical model of obesity and ER-positive breast cancer 0.02
ADAR1-editing of cellular and measles virus-derived duplex RNA 0.0
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation